Lilly Declares Third-Quarter 2021 Dividend
The board of directors of Eli Lilly and Company (NYSE: LLY) has announced a third-quarter 2021 dividend of $0.85 per share for common stockholders. This dividend will be paid on September 10, 2021, to shareholders recorded by the close of business on August 13, 2021. Lilly remains committed to delivering high-quality medicines and addressing real-world health needs as a leading global healthcare company.
- Dividend of $0.85 per share indicates strong financial health and confidence in continued cash flow.
- Consistent dividend payments can attract income-focused investors.
- Potential risks in pharmaceutical research and development could impact future dividend sustainability.
INDIANAPOLIS, June 29, 2021 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) (the "Board") has declared a dividend for the third quarter of 2021 of
The dividend is payable on September 10, 2021 to shareholders of record at the close of business on August 13, 2021.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY
Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) related to expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors. For a further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, please see Lilly's most recent Forms 10-K and 10-Q filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.
Refer to: | Molly McCully; mccully_molly@lilly.com; 317-478-5423 (Media) |
Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-declares-third-quarter-2021-dividend-301322467.html
SOURCE Eli Lilly & Company
FAQ
What is the dividend amount declared by Eli Lilly for the third quarter of 2021?
When will the third-quarter dividend be paid to shareholders?
What is the record date for the dividend payment by Eli Lilly?
Is Eli Lilly's dividend sustainable in the long term?
